Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jamie Kidd

2PUBLICATIONS
14CO-AUTHORS
Pacific Peoples life courseInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jul 04, 2025
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial.

Paul Spearman, Hong Jin, Peng Xiao

|Oct 25, 2023
Intranasal parainfluenza virus type 5 (PIV5)-vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study.

Paul Spearman, Hong Jin, Kristeene Knopp

Pageof 1

Frequent Collaborators

2 joint publications

Paul Spearman

2 joint publications

Kristeene Knopp

2 joint publications

Peng Xiao

2 joint publications

Marinka Tellier

2 joint publications

Samuel Wu

2 joint publications

Susan P John

2 joint publications

Francois J Villinger

2 joint publications

Biao He

1 joint publications

Matthew McGregor

1 joint publications

Barbara Freda

Frequent Collaborators

2 joint publications

Paul Spearman

2 joint publications

Kristeene Knopp

2 joint publications

Peng Xiao

2 joint publications

Marinka Tellier

Top Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Published on : Sep 28, 2022

1.9K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on : Feb 22, 2019

10.7K
See more related videos

Top Related Videos

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>
07:33

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine <em>In Vitro</em> and <em>In Vivo</em>

Published on : Sep 28, 2022

1.9K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on : Feb 22, 2019

10.7K
See more related videos